ReviewCurrent oncology (Toronto, Ont.)2023

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives.

Chiara Lazzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.